Back to Journals » Neuropsychiatric Disease and Treatment » Volume 1 » Issue 2

SJR OA
CiteScore
Impact Factor

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021


       

Archive: Volume 1, 2005


Letter - Epi-inositol is ineffctive in Porsolt Forced Swim Test model of depression

Alona Shaldubina, Haim Einat, Yuly Bersudsky, RH Belmaker

Neuropsychiatric Disease and Treatment 2005, 1:189-190

Published Date: 15 July 2005

Letter - Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disoder patients

Kaplan Zeev, Matar Michael, Kamin Ram, Cohen Hagit

Neuropsychiatric Disease and Treatment 2005, 1:187-188

Published Date: 15 July 2005

Psychopathology and treatment responsiveness of patients with first-episode schizophrenia

Eva Cešková, Radovan Prikryl, Tomáš Kašpárek, Marta Ondrušová

Neuropsychiatric Disease and Treatment 2005, 1:179-185

Published Date: 15 July 2005

Increased serum interleukin-1β and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication

Andrea Schmitt, Thomas Bertsch, Heike Tost, Andrea Bergmann, Uwe Henning, Ansgar Klimke, Peter Falkai

Neuropsychiatric Disease and Treatment 2005, 1:171-177

Published Date: 15 July 2005

Impact of an activities-based adult dementia care program

Margaret Higgins, Kathleen Koch, Linda S Hynan, Sandra Carr, Kathleen Byrnes, Myron F Weiner

Neuropsychiatric Disease and Treatment 2005, 1:165-169

Published Date: 15 July 2005

The relationship between dementia severity and rest/activity circadian rhythms

Phil Gehrman, Matthew Marler, Jennifer L Martin, Tamar Shochat, Jody Corey-Bloom, Sonia Ancoli-Israel

Neuropsychiatric Disease and Treatment 2005, 1:155-163

Published Date: 15 July 2005

Changes in peripheral benzodiazepine receptors in patients with bipolar disorder

Donatella Marazziti, Bernardo Dell’Osso, Stefano Baroni, Irene Masala, Elena Di Nasso, Gino Giannaccini, Liliana Dell’Osso

Neuropsychiatric Disease and Treatment 2005, 1:151-154

Published Date: 15 July 2005

Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations

Kristin Brousseau, David Arciniegas, Susie Harris

Neuropsychiatric Disease and Treatment 2005, 1:145-149

Published Date: 15 July 2005

Conceptualization of depression in Parkinson’s disease

Jeffrey CL Looi, May Matias, Michelle J Ruzich

Neuropsychiatric Disease and Treatment 2005, 1:135-143

Published Date: 15 July 2005

Genetic and molecular aspects of spinocerebellar ataxias

Viktor Honti, László Vécsei

Neuropsychiatric Disease and Treatment 2005, 1:125-133

Published Date: 15 July 2005

Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model

Frasia Oosthuizen, Gregers Wegener, Brian H Harvey

Neuropsychiatric Disease and Treatment 2005, 1:109-123

Published Date: 15 July 2005

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders

Stan Kutcher, Sarah J Brooks, David M Gardner, Bill Honer, Lili Kopala, Alain Labelle, Pierre Lalonde, Ashok Malla, Heather Milliken, Jorge Soni, Richard Williams

Neuropsychiatric Disease and Treatment 2005, 1:89-108

Published Date: 15 July 2005